Alpha Tau Medical Ltd (DRTS) has released an update. Alpha Tau Medical Ltd., a pioneer in alpha-radiation cancer therapy, has successfully treated its first patient with recurrent lung cancer ...
JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha ...
H.C. Wainwright has maintained a Buy rating and a $9.00 price target on shares of Alpha Tau Medical Ltd. (NASDAQ: DRTS). The endorsement follows the recent initiation of a clinical trial by Alpha ...
The US Food and Drug Administration (FDA) has granted approval for Alpha Tau Medical’s investigational device exemption (IDE) application to initiate a study of its Alpha diffusing alpha ...
During the October meeting of the Alpha Tau Chapter of Alpha Delta Kappa, International Honorary Organization for Women Educators, a Founder’s Day program was provided by Susan Gracie, left, and Rita ...
JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, ...
During the October meeting of the Alpha Tau Chapter of Alpha Delta Kappa, International Honorary Organization for Women Educators, a Founder’s Day program was provided by Susan Gracie ...
Hostesses for the Alpha Tau chapter (WV) of Alpha Delta Kappa October meeting, from left, Diane Bowers, Michelle Lewis and Ginger Greene. (Submitted photo) NEW CUMBERLAND — The Alpha Tau chapter ...
They first isolated the part of the protein that does the antiviral dirty work, called the RING domain, and then linked it to two different tau-targeting molecules: a miniature antibody (nanobody ...
Register to read this story and more for free. Signing up for an account helps us improve your browsing experience.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback